For the first time, a novel TPGS-b-(PCL-ran-PGA) nanoparticle modified with polyethyleneimine was applied to be a vector of TRAIL and endostatin for cervical cancer gene therapy. This evidence concerns the gene COL18A1 and cervical carcinoma.